Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Operating Expenses: 2021-2024

Historic Operating Expenses for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $54.5 million.

  • Biofrontera's Operating Expenses fell 5.05% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.8 million, marking a year-over-year increase of 0.11%. This contributed to the annual value of $54.5 million for FY2024, which is 3.91% down from last year.
  • According to the latest figures from FY2024, Biofrontera's Operating Expenses is $54.5 million, which was down 3.91% from $56.7 million recorded in FY2023.
  • In the past 5 years, Biofrontera's Operating Expenses registered a high of $56.7 million during FY2023, and its lowest value of $47.3 million during FY2022.
  • For the 3-year period, Biofrontera's Operating Expenses averaged around $52.8 million, with its median value being $54.5 million (2024).
  • Its Operating Expenses has fluctuated over the past 5 years, first fell by 4.15% in 2022, then grew by 20.09% in 2023.
  • Yearly analysis of 4 years shows Biofrontera's Operating Expenses stood at $49.3 million in 2021, then fell by 4.15% to $47.3 million in 2022, then grew by 20.09% to $56.7 million in 2023, then dropped by 3.91% to $54.5 million in 2024.